Schleicher U M
Klinik für Strahlentherapie, RWTH Aachen.
Rofo. 1995 Dec;163(6):469-73. doi: 10.1055/s-2007-1016031.
Within the framework of the discussed introduction of mammography for breast cancer screening in Germany, we were interested in the actual status of breast cancer detection.
From 1990-1994, 1019 breast cancer patients with 1050 carcinomas were inquired during primary anamnesis whether the suspicious finding was first discovered by themselves, their physician at routine examination or in routine mammography.
In 71.14% of the cases, breast changes were first recognised by the patient, in 12.48% palpated by the physician and 16.38% were first seen at routine mammography. Cancers discovered by physicians or mammography were in statistically significant lower tumour and lymph node stages than those found by the patient and could more often be treated by breast-conserving regimes.
However, most breast cancers are still first discovered by the patient and are diagnosed at higher stages than those discovered by clinical examination or mammography.
在德国讨论引入乳腺钼靶筛查乳腺癌的框架内，我们对乳腺癌检测的实际状况感兴趣。
1990年至1994年期间，对1019例患有1050处癌灶的乳腺癌患者进行初次问诊，询问可疑发现是患者自己首次发现、医生在常规检查时发现还是在常规乳腺钼靶检查中发现。
在71.14%的病例中，乳房变化首先由患者识别，12.48%由医生触诊发现，16.38%首次在常规乳腺钼靶检查中发现。医生或乳腺钼靶检查发现的癌症在肿瘤和淋巴结分期上在统计学上显著低于患者发现的癌症，并且更常采用保乳治疗方案。
然而，大多数乳腺癌仍然首先由患者发现，并且与通过临床检查或乳腺钼靶检查发现的乳腺癌相比，诊断时处于更高分期。
